Fuji Pharma Co Ltd
TSE:4554

Watchlist Manager
Fuji Pharma Co Ltd Logo
Fuji Pharma Co Ltd
TSE:4554
Watchlist
Price: 1 317 JPY 1.7% Market Closed
Market Cap: 32.6B JPY

P/E
Price to Earnings

7.3
Current
9.1
Median
19.8
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
7.3
=
Market Cap
32.1B JPY
/
Net Income
4.4B JPY
Earnings Growth PEG
JP
Fuji Pharma Co Ltd
TSE:4554
Average P/E: 24.2
7.3
-14%
N/A
US
Eli Lilly and Co
NYSE:LLY
67.8
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
26.3
26%
1
DK
Novo Nordisk A/S
CSE:NOVO B
18.7
19%
1
CH
Roche Holding AG
SIX:ROG
17.7
16%
1.1
CH
Novartis AG
SIX:NOVN
18.7
16%
1.2
UK
AstraZeneca PLC
LSE:AZN
29.9
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.6
18%
0.6
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -55.5 N/A N/A
FR
Sanofi SA
PAR:SAN
19.9
28%
0.7

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
9
2-Years Forward
P/E
8.5
3-Years Forward
P/E
8.2